000 05042cam a2200625 i 4500
001 on1178868370
003 OCoLC
005 20221128212722.0
006 m d
007 cr |||||||||||
008 140708s2014 nyu ob 001 0 eng
010 _a 2020679602
040 _aDLC
_beng
_erda
_cDLC
_dN$T
_dE7B
_dYDXCP
_dOCLCF
_dEBLCP
_dSAV
_dSTF
_dOCLCO
_dOCLCA
_dOCLCO
019 _a890942048
_a914433448
_a923676305
_a928196009
_a992827141
020 _a9781633216013
_qebook
020 _a1633216012
020 _z1633215849
_qhbk.
020 _z9781633215849
_qhbk.
035 _a836693
_b(N$T)
035 _a(OCoLC)1178868370
_z(OCoLC)890942048
_z(OCoLC)914433448
_z(OCoLC)923676305
_z(OCoLC)928196009
_z(OCoLC)992827141
042 _apcc
072 7 _aMED
_x085000
_2bisacsh
049 _aMAIN
245 0 0 _aMacular edema :
_brisk factors, treatment options and long-term outcomes
_c
_h[E-Book]
264 1 _aNew York :
_bNova Publishers,
_c[2014]
300 _a1 online resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
490 1 _aEye and Vision Research Developments
504 _aIncludes bibliographical references and index.
588 _aDescription based on print version record and CIP data provided by publisher.
505 0 _aMACULAR EDEMA: RISK FACTORS, TREATMENT OPTIONS AND LONG-TERM OUTCOMES; MACULAR EDEMA: RISK FACTORS, TREATMENT OPTIONS AND LONG-TERM OUTCOMES; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: MANAGEMENT OF DIABETIC MACULAR EDEMA BY INTRAVITREAL ANTIANGIOGENIC DRUGS; ABSTRACT; INTRODUCTION; ROLE OF VEGF; PEGAPTANIB (MACUGEN�, PFIZER OPHTHALMICS); RANIBIZUMAB (LUCENTIS�, GENENTECH, NOVARTIS); BEVACIZUMAB (AVASTIN�, ROCHE, GENENTECH); AFLIBERCEPT (EYLEA�, BAYER, REGENERON PHARMACEUTICALS); TREATMENT PROTOCOLS; CONCLUSION; REFERENCES.
505 8 _aChapter 2: MANAGEMENT OF MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION BY INTRAVITREAL BEVACIZUMABABSTRACT; INTRODUCTION; PATHOGENESIS; TREATMENT; ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR; ANTIANGIOGENIC TREATMENT; INTRAVITREOUS BEVACIZUMAB IN BRVO; INTRAVITREOUS BEVACIZUMAB IN CRVO; ANTI-VEGF IN ISCHEMIC RETINA; TREATMENT PROTOCOLS; CONCLUSION; REFERENCES; Chapter 3: POSTOPERATIVE CYSTOID MACULAR EDEMA IN DIABETIC PATIENTS: PROPHYLAXIS AND MANAGEMENT; ABSTRACT; INTRODUCTION; PATHOGENESIS; PREOPERATIVE CARE; MANAGEMENT; REFERENCES; Chapter 4: MANAGEMENT OF DIABETIC MACULAR EDEMA.
505 8 _aABSTRACTINTRODUCTION; MANAGEMENT OF SYSTEMIC RISK FACTORS; LASER PHOTOCOAGULATION FOR DME; PHARMACOLOGICAL DME TREATMENT; COMBINATION THERAPY FOR DME MANAGEMENT; SURGICAL TREATMENT OF DME; TREATMENT GUIDELINES OF DME; CONCLUSION; REFERENCES; Chapter 5: CURRENT MANAGEMENT OF CHRONIC DIABETIC MACULAR OEDEMA; ABSTRACT; INTRODUCTION; EPIDEMIOLOGY OF DIABETIC MACULAR OEDEMA; PATHOPHYSIOLOGY OF CHRONIC DIABETIC MACULAR OEDEMA; INVESTIGATIONS FOR DMO; LASER TREATMENT IN THE MANAGEMENT OF CHRONIC DIABETIC MACULAR OEDEMA; ANTI-VEGF THERAPIES.
505 8 _aINTRAVITREAL STEROIDS TO TREAT CHRONIC DIABETIC MACULAR OEDEMADMO TREATMENT ALGORITHM; FUTURE MANAGEMENT OPTIONS; CONCLUSION; REFERENCES; Chapter 6: MACULAR EDEMA IN IMPORTANT TROPICAL INFECTIONS; ABSTRACT; INTRODUCTION; MACULAR EDEMA IN SOME IMPORTANT TROPICAL INFECTIONS; CONCLUSION; REFERENCES; Chapter 7: CYSTOID MACULAR EDEMA: A DIFFICULT OCULAR DISORDER TO CURE; ABSTRACT; INTRODUCTION; MACULAR HOLE; TREATMENT OF MACULAR EDEMA; CASE REPORT; DISCUSSION; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; INDEX.
520 _aMacular edema is a serious eye disorder that can be seen in many conditions. Central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) are frequent causes of decreased central visual acuity (VA) related to the appearance of macular edema (ME) and ischemia. This book discusses the risk factors, treatment options and long-term outcomes of macular edema. Some of the topics discussed include the management of diabetic macular edema; management of macular edema secondary to retinal vein occulsion by intravitreal bevacizumab; and macular edema in important tropical infections.
590 _aWorldCat record variable field(s) change: 650
650 0 _aMacula lutea
_xDiseases.
650 0 _aEdema.
650 0 _aMacula lutea.
650 0 _aEye
_xDiseases.
650 2 _aMacula Lutea
650 2 _aEdema
650 2 _aEye Diseases
700 1 _aDavison, Earl,
_eeditor.
830 0 _aEye and Vision Research Developments.
856 4 0 _uhttps://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=836693
_yKingston Hospital NHS Foundation Trust OpenAthens account holders click here for access
938 _aProQuest Ebook Central
_bEBLB
_nEBL3024678
938 _aebrary
_bEBRY
_nebr10918995
938 _aEBSCOhost
_bEBSC
_n836693
938 _aYBP Library Services
_bYANK
_n11975933
942 _n0
994 _a92
_bN$T
999 _c91919
_d91919